GOLD DANIEL ALLEN sold 7.5% of their position (1.23M shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $32.66M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 2/13/2026ACC: 0001193125-26-052128
-1.23M
Net shares
Net seller
$32.66M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
1.23M disposed
Non-Derivative Transactions5
Common Shares
Indirect
Shares
−425K
Price / share
$26.67
Trade value
$11.33M
% of position
2.6%
2/11/2026
16.35M→15.93M
Common Shares
Indirect
Shares
−150K
Price / share
$26.72
Trade value
$4.01M
% of position
0.9%
2/12/2026
15.93M→15.78M
Common Shares
Indirect
Shares
−275K
Price / share
$26.76
Trade value
$7.36M
% of position
1.7%
2/12/2026
15.78M→15.50M
Common Shares
Indirect
Shares
−150.78K
Price / share
$26.49
Trade value
$3.99M
% of position
1.0%
2/13/2026
15.50M→15.35M
Common Shares
Indirect
Shares
−225K
Price / share
$26.50
Trade value
$5.96M
% of position
1.5%
2/13/2026
15.35M→15.13M
Total
Net shares
−1.23M
Net value
-$32.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 2/11/2026 | S · Sale | −425K | $26.67 | $11.33M | 2.6% | 16.35M | 15.93M |
| Common Shares Indirect | 2/12/2026 | S · Sale | −150K | $26.72 | $4.01M | 0.9% | 15.93M | 15.78M |
| Common Shares Indirect | 2/12/2026 | S · Sale | −275K | $26.76 | $7.36M | 1.7% | 15.78M | 15.50M |
| Common Shares Indirect | 2/13/2026 | S · Sale | −150.78K | $26.49 | $3.99M | 1.0% | 15.50M | 15.35M |
| Common Shares Indirect | 2/13/2026 | S · Sale | −225K | $26.50 | $5.96M | 1.5% | 15.35M | 15.13M |
| Total | −1.23M | -$32.66M | ||||||
Derivative Transactions0
No derivative transactions reported